BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12193659)

  • 1. Cooperative activities of hematopoietic regulators recruit RNA polymerase II to a tissue-specific chromatin domain.
    Johnson KD; Grass JA; Boyer ME; Kiekhaefer CM; Blobel GA; Weiss MJ; Bresnick EH
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11760-5. PubMed ID: 12193659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta -globin locus control region (LCR) functions primarily by enhancing the transition from transcription initiation to elongation.
    Sawado T; Halow J; Bender MA; Groudine M
    Genes Dev; 2003 Apr; 17(8):1009-18. PubMed ID: 12672691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2.
    Anguita E; Hughes J; Heyworth C; Blobel GA; Wood WG; Higgs DR
    EMBO J; 2004 Jul; 23(14):2841-52. PubMed ID: 15215894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
    Gui CY; Dean A
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter.
    Sawado T; Igarashi K; Groudine M
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10226-31. PubMed ID: 11517325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
    Armstrong JA; Emerson BM
    Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting molecular steps in chromatin domain activation during hematopoietic differentiation.
    Kim SI; Bultman SJ; Jing H; Blobel GA; Bresnick EH
    Mol Cell Biol; 2007 Jun; 27(12):4551-65. PubMed ID: 17438135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of alpha-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34(+) cells in culture.
    Mahajan MC; Karmakar S; Newburger PE; Krause DS; Weissman SM
    Exp Hematol; 2009 Oct; 37(10):1143-1156.e3. PubMed ID: 19607874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.
    Gong QH; McDowell JC; Dean A
    Mol Cell Biol; 1996 Nov; 16(11):6055-64. PubMed ID: 8887635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic-specific activators establish an overlapping pattern of histone acetylation and methylation within a mammalian chromatin domain.
    Kiekhaefer CM; Grass JA; Johnson KD; Boyer ME; Bresnick EH
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14309-14. PubMed ID: 12379744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expression.
    Layon ME; Ackley CJ; West RJ; Lowrey CH
    J Mol Biol; 2007 Feb; 366(3):737-44. PubMed ID: 17196618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A WW domain-binding motif within the activation domain of the hematopoietic transcription factor NF-E2 is essential for establishment of a tissue-specific histone modification pattern.
    Kiekhaefer CM; Boyer ME; Johnson KD; Bresnick EH
    J Biol Chem; 2004 Feb; 279(9):7456-61. PubMed ID: 14597626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing.
    Iler N; Goodwin AJ; McInerney J; Nemeth MJ; Pomerantz O; Layon ME; Lowrey CH
    Blood Cells Mol Dis; 1999 Feb; 25(1):47-60. PubMed ID: 10349513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region.
    Stamatoyannopoulos JA; Goodwin A; Joyce T; Lowrey CH
    EMBO J; 1995 Jan; 14(1):106-16. PubMed ID: 7828582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1.
    Vakoc CR; Letting DL; Gheldof N; Sawado T; Bender MA; Groudine M; Weiss MJ; Dekker J; Blobel GA
    Mol Cell; 2005 Feb; 17(3):453-62. PubMed ID: 15694345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region.
    Li Q; Zhang M; Duan Z; Stamatoyannopoulos G
    Genomics; 1999 Oct; 61(2):183-93. PubMed ID: 10534403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct mechanisms control RNA polymerase II recruitment to a tissue-specific locus control region and a downstream promoter.
    Johnson KD; Christensen HM; Zhao B; Bresnick EH
    Mol Cell; 2001 Aug; 8(2):465-71. PubMed ID: 11545748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic footprinting and sequencing of human beta-globin locus. Tissue specificity and cell line artifact.
    Reddy PM; Stamatoyannopoulos G; Papayannopoulou T; Shen CK
    J Biol Chem; 1994 Mar; 269(11):8287-95. PubMed ID: 8132552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line.
    Amrolia PJ; Ramamurthy L; Saluja D; Tanese N; Jane SM; Cunningham JM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10051-6. PubMed ID: 9294161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.